8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): December 10, 2013

ALEXANDRIA REAL ESTATE EQUITIES, INC.

(Exact name of registrant as specified in its charter)

Maryland	1-12993	95-4502084
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

385 East Colorado Boulevard, Suite 299	91101
Pasadena, California
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (626) 578-0777

- - - - - - - - - - - - - - - - - - - -

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))

la-1232892

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 10, 2013, the Board of Directors (the “Board”) of Alexandria Real Estate Equities, Inc. (the “Company”) elected Steven R. Hash as a director of the Company, to serve until the 2014 annual meeting of stockholders of the Company and until his successor is duly elected and qualifies. The Board also appointed Mr. Hash as a member of its Audit Committee and Nominating & Governance Committee and has determined that Mr. Hash is independent in accordance with applicable New York Stock Exchange listing standards and Securities and Exchange Commission rules and is an “audit committee financial expert” within the meaning of the rules of the Securities and Exchange Commission.

Mr. Hash is currently the President and Chief Operating Officer of Renaissance Macro Research, LLC, an equity research and trading firm focused on macro research in the investment strategy, economics and Washington policy sectors, which he co-founded in 2012. Between 1993 and 2012, Mr. Hash held various leadership positions with Lehman Brothers (and its successor, Barclays Capital), including Global Head of Real Estate Investment Banking (2006 to 2012), Chief Operating Officer of Global Investment Banking (2008 to 2011), Director of Global Equity Research (2003 to 2006), Director of U.S. Equity Research (1999 to 2003), and Senior Equity Research Analyst (1993 to 1999). From 1990 to 1993, Mr. Hash held various positions with Oppenheimer & Company’s Equity Research Department, including senior research analyst. He began his career in 1988 as an auditor for the accounting and consulting firm of Arthur Andersen & Co. Mr. Hash received a Bachelor of Arts degree in Business Administration from Loyola University, and a Master of Business Administration degree from the Stern School of Business at New York University.

On his initial election to the Board and pursuant to the terms of the Company’s Amended and Restated 1997 Stock Award and Incentive Plan, Mr. Hash received a grant of 1,000 shares of restricted stock of the Company, which shares vest in full on the second anniversary of the date of grant. Mr. Hash will also generally participate in the compensation arrangements provided to the Company’s independent directors, as described in the Company's Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 19, 2013, under the caption “Director Compensation.”

The press release announcing Mr. Hash’s election as a director of the Company is attached hereto as Exhibit 99.1 and is filed herewith.

Item 9.01    Financial Statements and Exhibits

(d)    Exhibits

99.1    Press Release, dated December 16, 2013.

la-1232892

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Date:    December 16, 2013            By:    /s/ Dean A. Shigenaga

Dean A. Shigenaga

Chief Financial Officer

la-1232892

EX-99.1

EXHIBIT 99.1

For Immediate Release

Contact: Joel S. Marcus
Chairman, Chief Executive Officer, & Founder
Alexandria Real Estate Equities, Inc.
626-578-9693

Alexandria Real Estate Equities, Inc. Elects Steven R. Hash to the Company's Board of Directors

Pasadena, California, December 16, 2013 -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced today that the Company's Board of Directors has elected Steven R. Hash as an independent director. The Company’s Board of Directors has also appointed Mr. Hash as a member of its Audit Committee and Nominating & Governance Committee. Mr. Hash is an “audit committee financial expert” within the meaning of the rules of the Securities and Exchange Commission (“SEC”) and is an independent director in accordance with New York Stock Exchange (“NYSE”) listing standards and SEC rules. His term will run until the 2014 annual meeting of stockholders of the Company.

Mr. Hash is the President and Chief Operating Officer, and a Co-Founder, of Renaissance Macro Research, LLC (RenMac), a leading boutique equity research and trading business focused on macro research in the investment strategy, economics, and Washington policy sectors. Prior to co-founding Renaissance Macro Research, Mr. Hash spent almost 20 years at Barclays Capital/Lehman Brothers where he served in various leadership positions, including Global Head of Real Estate Investment Banking, Chief Operating Officer of Global Investment Banking, Global Head of Equity Research, U.S. Head of Equity Research, and Senior Equity Research Analyst. During his tenure at Lehman Brothers, Mr. Hash was ranked as a top analyst in the Institutional Investor All-American equity research survey and the Greenwich Associates Survey for multiple years, and was instrumental in moving the firm to #1 in the Institutional Investor All-American equity research survey in 2003, from #9 in 1999. Mr. Hash began his career as a senior research analyst covering the REIT industry at Oppenheimer & Company, and as a senior auditor for the accounting and consulting firm of Arthur Andersen & Company. He received a Bachelor of Arts degree from Loyola University and an MBA degree from New York University.

“We are honored and pleased to welcome Steve to our Board,” said Joel S. Marcus, Chairman, Chief Executive Officer, and Founder of Alexandria Real Estate Equities, Inc. “Steve’s depth of insight of the analyst and investor communities is unparalleled. Alexandria will greatly benefit from his unique expertise and knowledge of real estate investments while garnered during his highly successful career on Wall Street and now at RenMac, an esteemed equity research firm.”

About Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed investment-grade real estate investment trust (“REIT”), is the largest and leading REIT focused principally on owning, operating, developing, redeveloping and acquiring high-quality, sustainable real estate for the broad and diverse life science industry. Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, the San Francisco Bay Area, San Diego, New York City, Seattle, Maryland, and Research Triangle Park. As of September 30, 2013, Alexandria's asset base consisted of 30.9 million square feet, including 17.3 million RSF of operating assets and active value-creation projects and 13.6 million additional RSF through future ground-up development projects. Alexandria's high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. Investment-grade client tenants represented 50% of Alexandria's total annualized base rent as of September 30, 2013. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity, collaboration, and innovation through its best-in-class laboratory and office space adjacent to leading academic medical research centers, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community. We believe these advantages result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria, please visit www.are.com.